HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
- Country
- Germany
- Type
- Beneficiary
- Website
- www.helmholtz-hzi.de
- Grants received
- 89
Funding record
- 89 grants on record
- €45,670,335.17 awarded in total
- 2008–2026 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
43 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- KAROLINSKA INSTITUTET
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- EUROPEAN MOLECULAR BIOLOGY LABORATORY
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- HELSINGIN YLIOPISTO
- KATHOLIEKE UNIVERSITEIT LEUVEN
Calls from this organisation
No published calls from this organisation.
Grants received
- Unraveling the Impact of Vaccination on Rinderpest Virus Evolution
- Next-gen Liquid Chromatography - Mass Spectrometry Technology for Unravelling the Plasma Proteome
- Diagnostic model and assay for personalized vaccine
- Comparative signature of Marburg virus cell activation as a blueprint for the identification of antiviral targets against newly emerging viruses
- Identification of novel viral entry factors and development of antiviral approaches
- Phylogenomic-driven Drug Discovery from Rhodococcus and Saccharomonospora using 2D and 3D Cell Cultures
- Inhibitors of ECF transporters as novel antibacterial agents
- Harnessing a novel CRISPR nuclease for programmable counterselection in human cells
- IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN
- Developing broad-spectrum antiviral drugs for pandemic preparedness
- Restoring Ecosystems to Stop the Threat Of Re - Emerging Infectious Disease
- Design and synthesis of novel inhibitors of the anti-infective target IspE
- NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN
- Antibiotic Lead Optimization
- Impact and viability of a novel mass PCR testing method as a pandemic-fighting strategy
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.